Chengyao Li

Dr. Chengyao Li


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2024 in Animals
Verified
Journal Article
Open access
PDF file
CWChengdong Wang
Chengdong Wang
WDWenwen Deng
Wenwen Deng
ZHZhi Huang
Zhi Huang
CLCaiwu Li
Caiwu Li
RWRongping Wei
Rongping Wei
DLDesheng Li
Desheng Li
Proper feeding and nutrition are vital for maintaining the health of giant pandas (GPs), yet the impact of dietary changes and gut microbiota on their nutrient utilization remains unclear. To address these uncertainties, we investigated nutrient intake and apparent digestibility, as well as gut microbiota composition across different age groups of giant pandas: sub-adults (SGPs), adults (AGPs), and geriatrics (GGPs). Our findings revealed notable shifts in dietary patterns from SGPs to GGPs. As they aged, significantly more bamboo shoots and less bamboo were consumed. Consequently, GGPs showed significantly reduced crude fiber (CF) intake and digestibility, while crude protein (CP) did not alter significantly. In addition, 16S rRNA microbial sequencing results showed that unidentified_Enterobacteriaceae and Streptococcus were the dominant genera among all age groups. The relative abundance of the genus Enterococcus in GGPs was significantly higher than that in SGPs and AGPs (p < 0.05). Overall, our results indicated the importance of bamboo shoots as a major source of protein in GGPs’ diet, which can effectively compensate for the certain nutritional loss caused by the reduction in bamboo intake. Age-related changes in bacterial abundance have an effect on specific nutrient apparent digestibility in the gut of GPs. The data presented in this study serve as a useful reference for nutritional management in different ages of GPs under healthy conditions.

3 June 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
CWChengdong Wang
Chengdong Wang
CLChengyao Li
Chengyao Li
LDLinhua Deng
Linhua Deng
MSMeg Sutherland Smith
Meg Sutherland Smith
RWRongping Wei
Rongping Wei
DLDesheng Li
Desheng Li
The giant panda (Ailuropoda melanoleuca), as an endemic and endangered species in China, has attracted much attention regarding its health issues. In recent years, certain diseases that affect giant pandas have gradually become important factors impacting their survival and breeding, including tumor diseases. Research on testicular cancer in giant pandas, in particular, has attracted the attention of scientific researchers because it poses a threat to individual reproductive function and population reproduction. This review systematically reviews the research progress of testicular cancer in giant pandas in recent years. Firstly, starting from case reports, the current research status of clinical manifestations, diagnostic methods and molecular mechanisms of testicular cancer in giant pandas was analyzed. Secondly, the commonly used treatment methods at present were discussed, including surgical resection, radiotherapy and chemotherapy, etc., and the advantages and disadvantages of these methods in practical applications were summarized. Furthermore, this article also conducts an in-depth exploration of the pathogenesis of testicular cancer in giant pandas, involving possible triggers such as genetic factors, environmental factors, and endocrine disorders. Based on the existing research results, this paper proposes a few future research directions, which will provide important support for the health management and population protection of giant pandas. Overall, although certain progress has been made in the research of testicular cancer in giant pandas, it still needs to be further deepened in order to provide a more powerful scientific basis for the healthcare and breeding of the endangered giant panda species.

3 May 2026 in Animals
Verified
Journal Article
Open access
PDF file
LLLK L
LK L
MXMaohua Xia
Maohua Xia
CHChengyao Hou
Chengyao Hou
DCDanyu Chen
Danyu Chen
CLChengyao Li
Chengyao Li
Xin YangXin Yang
Xin Yang
Although canine parvovirus (CPV) vaccination has been widely implemented, CPV continues to circulate in dog populations and poses a potential cross-species transmission risk to wildlife, including giant pandas. Recent increases in CPV-2c detection in China highlight the need for molecular surveillance and standardized immunoreagents for diagnosis and epitope mapping. This study aimed to isolate a representative CPV-2c strain from China and develop VP2-targeted nanobody-based recognition molecules to support antigen monitoring and detection optimization. Canine and giant panda samples were collected in Sichuan Province, and CPV was isolated in F81 cells, followed by VP2 gene sequencing and phylogenetic analysis. A secretion expression system in Bacillus subtilis was established to produce VP2-targeting nanobodies, and a canine Fc-fused format of Nb10 (Nb10-Fc) was constructed. Immunoreactivity was evaluated via immunoassays, and structural modeling and molecular docking were performed to predict binding interfaces. The results showed that CPV-2c was the dominant genotype in Sichuan, with CPV L4 being a representative strain that exhibited 100% identity in VP2 with a giant panda-derived CPV-2c strain. Nb10 and Nb10-Fc demonstrated strong reactivity in Western blotting and immunofluorescence assays. The Fc-fusion improved detection sensitivity, offering potential in vivo application benefits. This study provides a standardized VP2-specific nanobody and molecular system for CPV-2c surveillance, antigenic studies, and diagnostic optimization.

8 July 2026 in Animals
Verified
Journal Article
Open access
PDF file
YZYan Zhu
Yan Zhu
QTQian Tao
Qian Tao
CLChengyao Li
Chengyao Li
SLShanshan Ling
Shanshan Ling
MWMing Wei
Ming Wei
CWChengdong Wang
Chengdong Wang
Hypertension threatens the health of aging captive giant pandas, yet its molecular signatures remain poorly characterized. Here, multi-omics sequencing was applied to explore the molecular regulatory process of hypertension and the pharmacodynamic effect of levamlodipine on this endangered species. Six aged giant pandas were divided into hypertensive and normotensive groups (three hypertensive and three normotensive pandas) based on clinical phenotypes and blood pressure measurements. A multi-omics approach was employed, including blood RNA-seq, Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq), single-cell RNA-seq (scRNA-seq) of peripheral blood mononuclear cells, and time-series RNA-seq following levamlodipine administration. Our transcriptomic analysis revealed a statistically significant decline in ACE2 transcript abundance (Padj < 0.05), which suggests a possible shift in renin–angiotensin system signaling linked to hypertensive status in giant pandas. Single-cell analysis of 88,693 cells revealed that hypertension-associated genes were predominantly enriched in monocytes and T cells, implicating immune cell activation. Time-dependent transcriptional changes after levamlodipine administration. Temporal gene dynamics showed early activation of metabolic pathways followed by delayed inhibition of ion channels and calcium signaling. This study provides a transcriptional molecular perspective into the pathogenesis of hypertension in giant pandas, which is conducive to developing more effective antihypertensive treatment strategies, thereby protecting the health of this endangered species.